RMTG (Regenerative Medical Technology Group) Forward Dividend Yield %: 0.00% (As of Jun. 27, 2026)


What is Regenerative Medical Technology Group Forward Dividend Yield %?

Regenerative Medical Technology Group RMTG Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. The stock has 4 warning signs investors should review. Among 146 Biotechnology companies, Regenerative Medical Technology Group ranks worse than 684930.82% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of Regenerative Medical Technology Group is 0.00%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of Regenerative Medical Technology Group is 0.00%.

RMTG's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.525
* Ranked among companies with meaningful Forward Dividend Yield % only.

Regenerative Medical Technology Group's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Regenerative Medical Technology Group  (OTCPK:RMTG) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Regenerative Medical Technology Group Forward Dividend Yield % Related Terms

RMTG vs WINT, LIPO, CYTOF: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Regenerative Medical Technology Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's Forward Dividend Yield % falls into.


Regenerative Medical Technology Group Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Regenerative Medical Technology Group (RMTG) has a Forward Dividend Yield % of 0.00% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Regenerative Medical Technology Group and its competitors. According to the industry distribution chart, Regenerative Medical Technology Group ranks #999999 out of 146 companies in the Biotechnology industry.
Is Regenerative Medical Technology Group's Forward Dividend Yield % too high?
Regenerative Medical Technology Group's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Regenerative Medical Technology Group ranks #999999 out of 146 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Regenerative Medical Technology Group's Forward Dividend Yield % compare to WINT and LIPO?
According to the Biotechnology industry distribution chart, Regenerative Medical Technology Group ranks #999999 out of 146 companies for Forward Dividend Yield %. This places Regenerative Medical Technology Group in the lower half of its industry. The industry median Forward Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.53, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Regenerative Medical Technology Group and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regenerative Medical Technology Group's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.06, compared to a current price of $0.05 — trading 24.7% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.